These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15155765)

  • 21. Multiple domains interacting with Gs in the porcine calcitonin receptor.
    Orcel P; Tajima H; Murayama Y; Fujita T; Krane SM; Ogata E; Goldring SR; Nishimoto I
    Mol Endocrinol; 2000 Jan; 14(1):170-82. PubMed ID: 10628756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.
    Miller LJ; Chen Q; Lam PC; Pinon DI; Sexton PM; Abagyan R; Dong M
    J Biol Chem; 2011 May; 286(18):15895-907. PubMed ID: 21454562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
    Lee SM; Hay DL; Pioszak AA
    J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential determinants for peptide and non-peptidyl ligand binding to the motilin receptor. Critical role of second extracellular loop for peptide binding and action.
    Matsuura B; Dong M; Miller LJ
    J Biol Chem; 2002 Mar; 277(12):9834-9. PubMed ID: 11781320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy.
    Dal Maso E; Zhu Y; Pham V; Reynolds CA; Deganutti G; Hick CA; Yang D; Christopoulos A; Hay DL; Wang MW; Sexton PM; Furness SGB; Wootten D
    Biochem Pharmacol; 2018 Apr; 150():214-244. PubMed ID: 29454620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
    Ji Z; Hadac EM; Henne RM; Patel SA; Lybrand TP; Miller LJ
    J Biol Chem; 1997 Sep; 272(39):24393-401. PubMed ID: 9305898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.
    Dong M; Pinon DI; Miller LJ
    Regul Pept; 2002 Nov; 109(1-3):181-7. PubMed ID: 12409231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.
    Harikumar KG; Ball AM; Sexton PM; Miller LJ
    Regul Pept; 2010 Sep; 164(2-3):113-9. PubMed ID: 20541569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The function of extracellular cysteines in the human adrenomedullin receptor.
    Kuwasako K; Kitamura K; Uemura T; Nagoshi Y; Kato J; Eto T
    Hypertens Res; 2003 Feb; 26 Suppl():S25-31. PubMed ID: 12630808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
    Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
    J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling.
    Dong M; Wang Y; Pinon DI; Hadac EM; Miller LJ
    J Biol Chem; 1999 Jan; 274(2):903-9. PubMed ID: 9873030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
    Dong M; Lam PC; Orry A; Sexton PM; Christopoulos A; Abagyan R; Miller LJ
    J Biol Chem; 2016 Mar; 291(10):5172-84. PubMed ID: 26740626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
    Ittner LM; Koller D; Muff R; Fischer JA; Born W
    Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.
    Houssami S; Findlay DM; Brady CL; Myers DE; Martin TJ; Sexton PM
    Endocrinology; 1994 Jul; 135(1):183-90. PubMed ID: 8013352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
    Dong M; Li Z; Zang M; Pinon DI; Lybrand TP; Miller LJ
    J Biol Chem; 2003 Nov; 278(48):48300-12. PubMed ID: 14500709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitonin Receptor N-Glycosylation Enhances Peptide Hormone Affinity by Controlling Receptor Dynamics.
    Lee SM; Jeong Y; Simms J; Warner ML; Poyner DR; Chung KY; Pioszak AA
    J Mol Biol; 2020 Mar; 432(7):1996-2014. PubMed ID: 32035902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
    Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
    Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene.
    Yamin M; Gorn AH; Flannery MR; Jenkins NA; Gilbert DJ; Copeland NG; Tapp DR; Krane SM; Goldring SR
    Endocrinology; 1994 Dec; 135(6):2635-43. PubMed ID: 7988453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
    Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
    Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.